[Form 4] Streamline Health Solutions, Inc. Insider Trading Activity
Bryant J. Reeves, III, Chief Financial Officer of Streamline Health Solutions, Inc. (STRM), reported a disposition of common stock tied to the company's merger that became effective on 08/12/2025. Under the Merger Agreement, each share of common stock outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash per share.
The filing specifically notes that 9,499 restricted shares were included and were converted into cash equal to the number of shares multiplied by the Merger Consideration, less applicable withholding taxes. The Form 4 shows a reported amount of 13,515 shares listed in the beneficial ownership column following the reported transactions. The disclosure documents an insider cash settlement and the company's transition to being a wholly owned subsidiary of the acquirer.
Bryant J. Reeves, III, Chief Financial Officer di Streamline Health Solutions, Inc. (STRM), ha segnalato una cessione di azioni ordinarie collegata alla fusione della società divenuta effettiva il 08/12/2025. In base all'Accordo di Fusione, ogni azione ordinaria in circolazione immediatamente prima del Momento di Efficacia è stata annullata e convertita nel diritto a ricevere $5.34 in contanti per azione.
La comunicazione indica specificamente che sono state incluse 9,499 azioni vincolate, convertite in un corrispettivo in denaro pari al numero di azioni moltiplicato per la Controparte di Fusione, meno le ritenute fiscali applicabili. Il Modulo 4 mostra un importo riportato di 13,515 azioni nella colonna della proprietà beneficiaria dopo le operazioni segnalate. La disclosure documenta una liquidazione in contanti per l'insider e la trasformazione della società in una sussidiaria interamente controllata dall'acquirente.
Bryant J. Reeves, III, Director Financiero de Streamline Health Solutions, Inc. (STRM), informó una disposición de acciones comunes vinculada a la fusión de la compañía que entró en vigor el 08/12/2025. Según el Acuerdo de Fusión, cada acción común en circulación inmediatamente antes del Momento de Efectividad fue cancelada y convertida en el derecho a recibir $5.34 en efectivo por acción.
La presentación señala específicamente que se incluyeron 9,499 acciones restringidas, que fueron convertidas en efectivo equivalente al número de acciones multiplicado por la Consideración de Fusión, menos las retenciones fiscales aplicables. El Formulario 4 muestra una cantidad reportada de 13,515 acciones en la columna de propiedad beneficiaria tras las transacciones informadas. La divulgación documenta una liquidación en efectivo para el insider y la conversión de la compañía en una filial de propiedad total del adquirente.
Bryant J. Reeves, III님, Streamline Health Solutions, Inc. (STRM)의 최고재무책임자(CFO)는 회사의 합병이 08/12/2025에 발효되면서 이에 따른 보통주 처분을 신고했습니다. 합병계약에 따라 효력 발생 시점 직전의 모든 보통주는 취소되고 주당 $5.34의 현금을 받을 권리로 전환되었습니다.
신고서에는 9,499개의 제한주가 포함되어 있으며, 이는 주식 수에 합병 대가를 곱한 금액에서 적용되는 원천징수세를 공제한 현금으로 전환되었다고 명시되어 있습니다. Form 4에는 보고된 거래 이후 수익적 소유 칸에 13,515주가 기재되어 있습니다. 해당 공시는 내부자의 현금 합의와 회사가 인수자의 전액 출자 자회사가 된 사실을 문서화합니다.
Bryant J. Reeves, III, directeur financier de Streamline Health Solutions, Inc. (STRM), a déclaré une cession d'actions ordinaires liée à la fusion de la société devenue effective le 08/12/2025. Conformément à l'accord de fusion, chaque action ordinaire en circulation immédiatement avant le moment d'effet a été annulée et convertie en droit de recevoir $5.34 en espèces par action.
Le dépôt précise que 9,499 actions restreintes ont été incluses et converties en une somme en espèces égale au nombre d'actions multiplié par la contrepartie de fusion, moins les retenues fiscales applicables. Le formulaire 4 indique un montant déclaré de 13,515 actions dans la colonne de propriété bénéficiaire après les opérations signalées. La divulgation documente un règlement en espèces pour l'initié et la transformation de la société en une filiale en propriété exclusive de l'acquéreur.
Bryant J. Reeves, III, Chief Financial Officer von Streamline Health Solutions, Inc. (STRM), meldete eine Veräußerung von Stammaktien im Zusammenhang mit der Fusion des Unternehmens, die am 08/12/2025 wirksam wurde. Nach dem Fusionsvertrag wurde jede Stammaktie, die unmittelbar vor dem Wirksamkeitszeitpunkt ausgegeben war, annulliert und in den Anspruch auf $5.34 in bar je Aktie umgewandelt.
Die Einreichung weist ausdrücklich darauf hin, dass 9,499 eingeschränkte Aktien einbezogen wurden und in bar umgerechnet wurden, basierend auf der Anzahl der Aktien multipliziert mit der Fusionsgegenleistung, abzüglich der anwendbaren Quellensteuern. Das Formular 4 weist nach den gemeldeten Transaktionen einen gemeldeten Bestand von 13,515 Aktien in der Spalte für wirtschaftliches Eigentum aus. Die Offenlegung dokumentiert eine Barausgleichszahlung an einen Insider und die Umwandlung des Unternehmens in eine hundertprozentige Tochtergesellschaft des Erwerbers.
- Fixed cash consideration of $5.34 per share provides a clear, determinable cash exit for holders
- Restricted awards converted to cash ensures holders of unvested awards receive settlement value
- Merger achieved effective date, completing the transaction mechanics described in the Merger Agreement
- Issuer became a wholly owned subsidiary, eliminating public equity exposure for shareholders
- Cash proceeds on restricted awards are reduced by applicable withholding taxes
- Form 4 reports insider disposals, which reduce the reporting person's public equity position
Insights
TL;DR: Insider reported cash conversion at $5.34 per share as the company was merged and became a wholly owned subsidiary; this is material for shareholders.
The Form 4 confirms consummation of a merger structure in which outstanding common shares were cancelled and converted into a fixed cash payment of $5.34 per share, a definitive consideration that determines cash proceeds to former public shareholders. The filing also identifies 9,499 restricted shares that were cashed out subject to withholding. For investors, this is a conclusive liquidity event that settles equity claims in cash and removes ongoing public equity exposure.
TL;DR: The disclosure documents standard merger mechanics: share cancellation, cash-out of restricted awards, and conversion of the issuer into a wholly owned subsidiary.
The explanatory notes state that at the Effective Time every outstanding common share was cancelled and converted into the right to receive $5.34 in cash and that restricted stock awards were similarly converted into cash (net of withholding). The filing therefore documents final equity treatment under the Merger Agreement and confirms the issuer now survives as a wholly owned subsidiary of the parent—an outcome that changes governance, reporting status, and public ownership structure.
Bryant J. Reeves, III, Chief Financial Officer di Streamline Health Solutions, Inc. (STRM), ha segnalato una cessione di azioni ordinarie collegata alla fusione della società divenuta effettiva il 08/12/2025. In base all'Accordo di Fusione, ogni azione ordinaria in circolazione immediatamente prima del Momento di Efficacia è stata annullata e convertita nel diritto a ricevere $5.34 in contanti per azione.
La comunicazione indica specificamente che sono state incluse 9,499 azioni vincolate, convertite in un corrispettivo in denaro pari al numero di azioni moltiplicato per la Controparte di Fusione, meno le ritenute fiscali applicabili. Il Modulo 4 mostra un importo riportato di 13,515 azioni nella colonna della proprietà beneficiaria dopo le operazioni segnalate. La disclosure documenta una liquidazione in contanti per l'insider e la trasformazione della società in una sussidiaria interamente controllata dall'acquirente.
Bryant J. Reeves, III, Director Financiero de Streamline Health Solutions, Inc. (STRM), informó una disposición de acciones comunes vinculada a la fusión de la compañía que entró en vigor el 08/12/2025. Según el Acuerdo de Fusión, cada acción común en circulación inmediatamente antes del Momento de Efectividad fue cancelada y convertida en el derecho a recibir $5.34 en efectivo por acción.
La presentación señala específicamente que se incluyeron 9,499 acciones restringidas, que fueron convertidas en efectivo equivalente al número de acciones multiplicado por la Consideración de Fusión, menos las retenciones fiscales aplicables. El Formulario 4 muestra una cantidad reportada de 13,515 acciones en la columna de propiedad beneficiaria tras las transacciones informadas. La divulgación documenta una liquidación en efectivo para el insider y la conversión de la compañía en una filial de propiedad total del adquirente.
Bryant J. Reeves, III님, Streamline Health Solutions, Inc. (STRM)의 최고재무책임자(CFO)는 회사의 합병이 08/12/2025에 발효되면서 이에 따른 보통주 처분을 신고했습니다. 합병계약에 따라 효력 발생 시점 직전의 모든 보통주는 취소되고 주당 $5.34의 현금을 받을 권리로 전환되었습니다.
신고서에는 9,499개의 제한주가 포함되어 있으며, 이는 주식 수에 합병 대가를 곱한 금액에서 적용되는 원천징수세를 공제한 현금으로 전환되었다고 명시되어 있습니다. Form 4에는 보고된 거래 이후 수익적 소유 칸에 13,515주가 기재되어 있습니다. 해당 공시는 내부자의 현금 합의와 회사가 인수자의 전액 출자 자회사가 된 사실을 문서화합니다.
Bryant J. Reeves, III, directeur financier de Streamline Health Solutions, Inc. (STRM), a déclaré une cession d'actions ordinaires liée à la fusion de la société devenue effective le 08/12/2025. Conformément à l'accord de fusion, chaque action ordinaire en circulation immédiatement avant le moment d'effet a été annulée et convertie en droit de recevoir $5.34 en espèces par action.
Le dépôt précise que 9,499 actions restreintes ont été incluses et converties en une somme en espèces égale au nombre d'actions multiplié par la contrepartie de fusion, moins les retenues fiscales applicables. Le formulaire 4 indique un montant déclaré de 13,515 actions dans la colonne de propriété bénéficiaire après les opérations signalées. La divulgation documente un règlement en espèces pour l'initié et la transformation de la société en une filiale en propriété exclusive de l'acquéreur.
Bryant J. Reeves, III, Chief Financial Officer von Streamline Health Solutions, Inc. (STRM), meldete eine Veräußerung von Stammaktien im Zusammenhang mit der Fusion des Unternehmens, die am 08/12/2025 wirksam wurde. Nach dem Fusionsvertrag wurde jede Stammaktie, die unmittelbar vor dem Wirksamkeitszeitpunkt ausgegeben war, annulliert und in den Anspruch auf $5.34 in bar je Aktie umgewandelt.
Die Einreichung weist ausdrücklich darauf hin, dass 9,499 eingeschränkte Aktien einbezogen wurden und in bar umgerechnet wurden, basierend auf der Anzahl der Aktien multipliziert mit der Fusionsgegenleistung, abzüglich der anwendbaren Quellensteuern. Das Formular 4 weist nach den gemeldeten Transaktionen einen gemeldeten Bestand von 13,515 Aktien in der Spalte für wirtschaftliches Eigentum aus. Die Offenlegung dokumentiert eine Barausgleichszahlung an einen Insider und die Umwandlung des Unternehmens in eine hundertprozentige Tochtergesellschaft des Erwerbers.
FAQ
What transaction did the Form 4 for Streamline Health (STRM) report?
What was the cash consideration per share in the Streamline Health merger?
How many restricted shares were included in the reported conversion?
Who filed the Form 4 and what is their role at STRM?
What beneficial ownership amount is shown following the reported transactions?
